1. Neoadjuvant immunotherapy for advanced, resectable non–small cell lung cancer: A systematic review and meta‐analysis
   Yajing Wu et al, 2023, Cancer CrossRef
2. Does major pathological response after neoadjuvant Immunotherapy in resectable nonsmall-cell lung cancers predict prognosis? A systematic review and meta-analysis
   Yujia Chen et al, 2023, International Journal of Surgery CrossRef
3. Neoadjuvant chemoimmunotherapy achieved a pathologic complete response in stage IIIA lung adenocarcinoma harboring RET fusion: a case report
   Minqian Dai et al, 2024, Frontiers in Immunology CrossRef
4. Long survival after neoadjuvant and adjuvant camrelizumab plus chemotherapy and surgery in a patient with hepatoid adenocarcinoma of the lung: A case report
   Xuhua Huang et al, 2024, Human Vaccines & Immunotherapeutics CrossRef
5. Efficacy, safety, and survival of neoadjuvant immunochemotherapy in operable non-small cell lung cancer: a systematic review and meta-analysis
   Yue Zheng et al, 2023, Frontiers in Immunology CrossRef